Skip to main contentAI and Advanced
/
SHELTER · BSEBSE SENSEX77,472.94-0.24%BSE |
NIFTY 5024,207.75-0.52%NSE |
NIFTY BANK57,783.75+0.47%NSE |
NIFTY IT30,318.85-1.47%NSE |
NIFTY AUTO29,000.15-0.74%NSE |
NIFTY FMCG47,252.9-0.95%NSE |
NIFTY PHARMA26,626.3+0.23%NSE |
NIFTY 50023,559.2-0.22%NSE |
SH
BSE · Equity shares · Pharmaceuticals-0.90 · -2.65%
Shelter Pharma Ltd SHELTER
NSE:Not available
BSE:INR 33
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsAvailable · provider snapshot
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for SHELTER
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 33.9
Day rangeINR 32.15 — INR 33.91
52-week rangeINR 25.1 — INR 34
Volume12,000
Market cap54.85
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)39.84
Net Income (INR Cr)4.53
EPS2.69
Research path: Interpret Shelter Pharma Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
SHELTERShelter Pharma Ltd1d · INR · BSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
BSE reported results · INR crore
| Metric | Mar-26 | Sep-25 | FY25-26 |
|---|---|---|---|
| Revenue | 39.84 | 33.29 | 73.13 |
| Net Profit | 4.53 | 4.5 | 9.03 |
| EPS | 2.69 | 3.89 | 6.58 |
| Cash EPS | 2.86 | 4.06 | 5.68 |
| OPM % | 16.26 | 18.82 | 17.42 |
| NPM % | 11.36 | 13.52 | 12.34 |
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m16.26
Net Profit Margin 12m11.36
Valuation
Price to Sale Ratio1.38
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
- Promoter and promoter group
- 44.38%
- Public shareholders
- 55.62%
- Other shareholders
- 0.00%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015 Completion And Commencement Of Dispatch Of Export OrderBSE corporate filing · 25 Aug 2026, 5:30 am
Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015 Completion And Commencement Of Dispatch Of Export OrderBSE corporate filing · 24 Aug 2026, 5:30 am
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - New Product Launch.BSE corporate filing · 21 Aug 2026, 5:30 am
Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015
Completion And Commencement Of Dispatch Of Export OrderBSE corporate filing · 20 Aug 2026, 5:30 am
Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-
Completion And Commencement Of Dispatch Of Export OrderBSE corporate filing · 10 Aug 2026, 5:30 am
Announcement under Regulation 30 (LODR)-Change in DirectorateBSE corporate filing · 31 Jul 2026, 5:30 am
Corporate actions
Events
- board MeetingsResults
- corporate ActionsFinal Dividend 0.35
- corporate ActionsFinal Dividend 0.33
- board MeetingsPreferential Issue of shares
- board MeetingsPreferential Issue of shares
- board MeetingsResults
- board MeetingsGeneral
- board MeetingsPreferential Issue of shares
ShareKeyX Community
Discussion and sentiment for Shelter Pharma Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Not available
Company facts
- Industry
- Pharmaceuticals
- Sector
- Healthcare
- Website
- www.shelter.co.in
- Address
- Shelter Nagar, Near S. T. Bus Stand, Himatnagar , Gujarat, 383001
- NSE Code
- SHELTER
- BSE Code
- 543963
- Listing date
- 23 Aug 2023
- Face value
- 10
- Market lot
- 3,000
- CIN
- L24233GJ2007PLC051956
- Company email
- info@shelter.co.in
- Company phone
- 277-2296038
Leadership and officers
- Managing Director
- Mr. Mustaqim Nisarahmed Sabugar
- Director
- Mr. Shakil Nisarahmed Sabugar
- Director
- Ms. Parvezbanu Mohamed Rafiq Idariya
- Director
- Mr. Mosinkhan Gafarkhan Pathan
- Director
- Mr. Riyajahmed Abdulrauf Sabugar
- Non - Executive Independent Director
- Ms. Vinita Shivraj Gadhvi
- Company Secretary & Compliance Officer
- Mr. Aarefa Kutub Kapasi
Questions
Stock FAQ
What is the symbol and ISIN of Shelter Pharma Ltd?
Shelter Pharma Ltd has the symbol SHELTER and ISIN - INE013V01011.
What is the current price of Shelter Pharma Ltd?
Shelter Pharma Ltd is currently trading at INR 33.00.
What are the year high and year low of Shelter Pharma Ltd?
Shelter Pharma Ltd has a year high of INR 34.00 and a year low of INR 25.10.
What is the market capitalization of Shelter Pharma Ltd?
Shelter Pharma Ltd has a market capitalization of INR 54.85 crore.
What is the P/E ratio of Shelter Pharma Ltd?
Shelter Pharma Ltd has a P/E ratio of NA.
What is the dividend yield of Shelter Pharma Ltd?
Shelter Pharma Ltd has a dividend yield of NA.
How is the financial performance of Shelter Pharma Ltd based on revenue, net income, and EPS?
Shelter Pharma Ltd has revenue of INR 39.84 crore, net income of INR 4.53 crore, and EPS of NA.
What is the book value of Shelter Pharma Ltd?
Shelter Pharma Ltd has a book value of NA.
What is the debt-to-equity ratio of Shelter Pharma Ltd?
Shelter Pharma Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Shelter Pharma Ltd?
Shelter Pharma Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 1.38.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.